









Markets
/
Stocks
/
nasdaq-holx
/

Hologic Inc

HOLX

75.602USD

-0.038-0.05%

Market hours （ET）Quotes delayed by 15 min

19.90BMarket Cap

31.16P/E TTM



Hologic Inc

75.602

-0.038-0.05%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Hologic Inc

Currency: USD Updated: 2026-03-24

Key Insights

Hologic Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 56 out of 209 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 75.15.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Hologic Inc's Score

Industry at a Glance

Industry Ranking

56 / 209

Overall Ranking

147 / 4547

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

Hologic Inc Highlights

StrengthsRisks

Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 4.10B.

Fairly Valued

The company’s latest PE is 31.13, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 217.20M shares, decreasing 8.64% quarter-over-quarter.

Held by CI Select Canadian Equity Fund

Star Investor CI Select Canadian Equity Fund holds 6.00K shares of this stock.

Analyst Rating

Based on 18 analysts

Hold

Current Rating

75.154

Target Price

-0.34%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-03-24

The current financial score of Hologic Inc is 7.70, ranking 58 out of 209 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 1.05B, representing a year-over-year increase of 2.54%, while its net profit experienced a year-over-year increase of 10.90%.

Score

Industry at a Glance

Previous score

7.70

Change



Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

6.27

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

7.37

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

7.75

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.11

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

Hologic Inc's Company Valuation

Currency: USD Updated: 2026-03-24

The current valuation score of Hologic Inc is 6.84, ranking 144 out of 209 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 31.13, which is 34.41% below the recent high of 41.85 and 38.87% above the recent low of 19.03.

Score

Industry at a Glance

Previous score

6.84

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 56/209

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-03-24

The current earnings forecast score of Hologic Inc is 6.00, ranking 175 out of 209 in the Healthcare Equipment & Supplies industry. The average price target is 76.00, with a high of 79.00 and a low of 70.00.

Score

Industry at a Glance

Previous score

6.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 18 analysts

Hold

Current Rating

75.154

Target Price

-0.34%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Hologic Inc

HOLX

Boston Scientific Corp

BSX

Intuitive Surgical Inc

ISRG

Edwards Lifesciences Corp

Veeva Systems Inc

VEEV

Thermo Fisher Scientific Inc

TMO

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-03-24

The current price momentum score of Hologic Inc is 5.40, ranking 179 out of 209 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 75.87 and the support level at 75.12, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

3.83

Change

1.57

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(2)

Buy(3)

Indicators

Value

Direction

MACD(12,26,9)

0.002

Buy

RSI(14)

58.133

Neutral

STOCH(KDJ)(9,3,3)

80.731

Buy

ATR(14)

0.250

Low Volatility

CCI(14)

56.721

Neutral

Williams %R

26.667

Buy

TRIX(12,20)

0.008

Sell

StochRSI(14)

77.337

Sell

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

75.416

Buy

MA10

75.302

Buy

MA20

75.408

Buy

MA50

75.185

Buy

MA100

74.891

Buy

MA200

70.841

Buy

Institutional Confidence

Currency: USD Updated: 2026-03-24

The current institutional shareholding score of Hologic Inc is 10.00, ranking 1 out of 209 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 97.29%, representing a quarter-over-quarter decrease of 3.14%. The largest institutional shareholder is The Vanguard, holding a total of 25.98M shares, representing 11.64% of shares outstanding, with 2.92% decrease in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

26.11M

-2.20%

BlackRock Institutional Trust Company, N.A.

12.44M

-3.99%

State Street Investment Management (US)

9.98M

-1.21%

Manulife Investment Management (North America) Limited

10.45M

-5.19%

T. Rowe Price Investment Management, Inc.

21.55M

-10.52%

Geode Capital Management, L.L.C.

5.90M

+1.18%

Victory Capital Management Inc.

5.47M

-0.52%

Risk Assessment

Currency: USD Updated: 2026-03-24

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Hologic Inc is 9.95, ranking 1 out of 209 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.70. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.